TSC2 and cancer: Disruption of the signaling pathway moderated by TSC1/TSC2 inhibition complex is often found in cancer development; in particular, loss of TSC2 function leads to hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1), a protein complex responsible for activation of protein translation [21,64].